Acura Pharmaceuticals reports Q3 results
Acura Pharmaceuticals (OTCQB:ACUR): Q3 GAAP EPS of $0.00.Revenue of $0.27M (-34.1% Y/Y)Press Release
In the US OTC market, the stock price of Acur.us (Acur.us) surged 5.48% in early trading to $0.570 due to intraday changes
At 21:51 on October 26, 2021, Beijing time, Acur.us (Acur.us) shares in the US OTC market changed, and the stock price rose sharply by 5.48%. As of press release, the stock was reported at $0.570 per share, with a trading volume of 4,345 shares, a turnover rate of 0.01%, and an amplitude of 5.50%. According to recent earnings data, the stock achieved operating income of $613000.00, net profit - $387000.00, earnings per share - $0.01, gross profit --, price-earnings ratio of -11.39 times. In terms of institutional ratings, there are currently no institutions making decisions on this stock”
Intraday changes in the US OTC market Acur.us (Acur.us) rose sharply by 5.77% to $0.550
At 23:36 on October 25, 2021, Beijing time, Acur.us (Acur.us) shares in the US OTC market fluctuated, and the stock price rose rapidly by 5.77%. As of press release, the stock was reported at $0.550 per share, with a trading volume of 303 shares, a turnover rate of 0.00%, and an amplitude of 0.00%. According to recent earnings data, the stock achieved operating income of $613000.00, net profit - $387000.00, earnings per share - $0.01, gross profit --, price-earnings ratio of -11.00 times. In terms of institutional ratings, there are currently no institutions that have “bought” this stock
The stock price of Acur.us Pharmaceuticals (Acur.us) in the US OTC market plummeted 5.68% in early trading due to intraday changes
At 22:22 on October 21, 2021, Beijing time, Acur.us (Acur.us) shares in the US OTC market changed, and the stock price fell rapidly by 5.68%. As of press release, the stock reported $0.565 per share, with a trading volume of 2,833 shares, a turnover rate of 0.00%, and an amplitude of 2.09%. According to recent earnings data, the stock achieved operating income of $613000.00, net profit - $387000.00, earnings per share - $0.01, gross profit --, price-earnings ratio of -11.39 times. In terms of institutional ratings, there are currently no institutions making decisions on this stock”
The intraday stock price of Acur.us (Acur.us) surged 6.02% in the US OTC market
At 2:51 on October 21, 2021, Beijing time, Acur.us (Acur.us) shares in the US OTC market fluctuated, and the stock price rose sharply by 6.02%. As of press release, the stock was reported at $0.599 per share, with a trading volume of 2001 shares, a turnover rate of 0.00%, and an amplitude of 5.13%. According to recent earnings data, the stock achieved operating income of $613000.00, net profit - $387000.00, earnings per share - $0.01, gross profit --, price-earnings ratio of -11.98 times. In terms of institutional ratings, there are currently no institutions making decisions on this stock”
Acura Pharmaceuticals Inc, Inst Holders, 1Q 2020 (ACUR)
DJ Acura Pharmaceuticals Inc, Inst Holders, 1Q 2020 (ACUR) The following table shows the largest shareholders in ACURA PHARMACEUTICALS INC COM (ACUR) for the quarter ended March 31, 2020, listed
Acura Pharmaceuticals 2Q Rev $46,000 >ACUR
*DJ Acura Pharmaceuticals 2Q Loss/Shr 15c >ACUR (MORE TO FOLLOW) Dow Jones Newswires (212-416-2800) February 10, 2020 16:18 ET (21:18 GMT) *DJ Acura Pharmaceuticals 2Q Loss $3.34M >
Acura Pharmaceuticals Inc, Inst Holders, 4Q 2019 (ACUR)
DJ Acura Pharmaceuticals Inc, Inst Holders, 4Q 2019 (ACUR) The following table shows the largest shareholders in ACURA PHARMACEUTICALS INC COM (ACUR) for the quarter ended December 31, 2019, l
Acura Pharmaceuticals Inc, Inst Holders, 2Q 2019 (ACUR)
DJ Acura Pharmaceuticals Inc, Inst Holders, 2Q 2019 (ACUR) The following table shows the largest shareholders in ACURA PHARMACEUTICALS INC COM (ACUR) for the quarter ended June 30, 2019, liste
Acura Pharmaceuticals Inc, Inst Holders, 1Q 2019 (ACUR)
DJ Acura Pharmaceuticals Inc, Inst Holders, 1Q 2019 (ACUR) The following table shows the largest shareholders in ACURA PHARMACEUTICALS INC COM (ACUR) for the quarter ended March 31, 2019, list
DJ Acura Pharmaceuticals Inc, Inst Holders, 4Q 2018 (ACUR)
DJ Acura Pharmaceuticals Inc, Inst Holders, 4Q 2018 (ACUR) The following table shows the largest shareholders in ACURA PHARMACEUTICALS INC COM (ACUR) for the quarter ended December 31, 2018, l
Press Release: Acura Pharmaceuticals Announces -2-
*DJ Acura Pharmaceuticals 3Q Loss/Shr 5c >ACUR (MORE TO FOLLOW) Dow Jones Newswires (212-416-2800) November 27, 2018 16:15 ET (21:15 GMT) Press Release: Acura Pharmaceuticals Announces
*DJ Acura Pharmaceuticals 3Q Loss/Shr 5c >ACUR
*DJ Acura Pharmaceuticals 3Q Loss/Shr 5c >ACUR (MORE TO FOLLOW) Dow Jones Newswires (212-416-2800) November 27, 2018 16:15 ET (21:15 GMT) Copyright (c) 2018 Dow Jones & Company,
*DJ Acura Pharmaceuticals 2Q Loss/Shr 6c >ACUR
*DJ Acura Pharmaceuticals 2Q Loss/Shr 6c >ACUR (MORE TO FOLLOW) Dow Jones Newswires (212-416-2800) August 14, 2018 16:15 ET (20:15 GMT) Copyright (c) 2018 Dow Jones & Company, In
No Data